Roche today announced the European Commission (EC) has approved faricimab (Vabysmo) for the treatment of neovascular or ‘wet’ age-related macular degenerat
Read More
/cloudfront-us-east-2.images.arcpublishing.com/reuters/I3BYYDLGPNOORN5UMU6HPECDSA.jpg)